Evidence map›Paper›PMID 25999344›Full record

ArticleNucleic acids research2015

TRF1 and TRF2 binding to telomeres is modulated by nucleosomal organization.

Alessandra Galati, Emanuela Micheli, Claudia Alicata, Tiziano Ingegnere, Alessandro Cicconi, Miriam Caroline Pusch, Marie-Josèphe Giraud-Panis, Eric Gilson, Stefano Cacchione

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Emerging roles of telomeric chromatin alterations in cancer.Journal of experimental & clinical cancer research : CR · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Alessandra GalatiDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, 00185 Rome, Italy Institute Pasteur-Fondazione Cenci-Bolognetti, Sapienza University of Rome, 00185 Rome, Italy.
Emanuela MicheliDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, 00185 Rome, Italy Institute Pasteur-Fondazione Cenci-Bolognetti, Sapienza University of Rome, 00185 Rome, Italy.
Claudia AlicataDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, 00185 Rome, Italy.
Tiziano IngegnereDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, 00185 Rome, Italy.
Alessandro CicconiDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, 00185 Rome, Italy Institute Pasteur-Fondazione Cenci-Bolognetti, Sapienza University of Rome, 00185 Rome, Italy.
Miriam Caroline PuschAdolf-Butenandt-Institut, Ludwig-Maximilians-Universität, 80336 München, Germany.
Marie-Josèphe Giraud-PanisInstitute for Research on Cancer and Aging, Nice (IRCAN) CNRS UMR 7284/INSERM U1081, University of Nice Sophia Antipolis, 06107 Nice, France.
Eric GilsonInstitute for Research on Cancer and Aging, Nice (IRCAN) CNRS UMR 7284/INSERM U1081, University of Nice Sophia Antipolis, 06107 Nice, France Department of Medical Genetics, Hospital, CHU of Nice, 06202 Nice, France.
Stefano CacchioneDepartment of Biology and Biotechnology 'Charles Darwin', Sapienza University of Rome, 00185 Rome, Italy Institute Pasteur-Fondazione Cenci-Bolognetti, Sapienza University of Rome, 00185 Rome, Italy stefano.cacchione@uniroma1.it.
Sapienza University of Rome · ITCentre National de la Recherche Scientifique · FRInserm · FRIstituto Pasteur · ITLudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ends of eukaryotic chromosomes need to be protected from the activation of a DNA damage response that leads the cell to replicative senescence or apoptosis. In mammals, protection is accomplished by a six-factor complex named shelterin, which organizes the terminal TTAGGG repeats in a still ill-defined structure, the telomere. The stable interaction of shelterin with telomeres mainly depends on the binding of two of its components, TRF1 and TRF2, to double-stranded telomeric repeats. Tethering of TRF proteins to telomeres occurs in a chromatin environment characterized by a very compact nucleosomal organization. In this work we show that binding of TRF1 and TRF2 to telomeric sequences is modulated by the histone octamer. By means of in vitro models, we found that TRF2 binding is strongly hampered by the presence of telomeric nucleosomes, whereas TRF1 binds efficiently to telomeric DNA in a nucleosomal context and is able to remodel telomeric nucleosomal arrays. Our results indicate that the different behavior of TRF proteins partly depends on the interaction with histone tails of their divergent N-terminal domains. We propose that the interplay between the histone octamer and TRF proteins plays a role in the steps leading to telomere deprotection.

Indexed as

Binding SitesDNAHistonesNucleosomesProtein BindingProtein Structure, TertiaryRepetitive Sequences, Nucleic AcidTelomereTelomeric Repeat Binding Protein 1Telomeric Repeat Binding Protein 2DNAHistonesNucleosomesTelomeric Repeat Binding Protein 1Telomeric Repeat Binding Protein 2

Identifiers

PMID25999344
PMCPMC4499135
OpenAlexW1514480115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.